Dianthus Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 106.3% | 106.3% | — |
| FY2017 | 84.3% | 84.3% | -65.2% |
| FY2018 | -39.5% | -39.5% | -36.6% |
| FY2019 | -54.4% | -54.4% | -47.5% |
| FY2020 | -52.1% | -52.1% | -46.4% |
| FY2021 | 412.4% | 412.4% | -37.5% |
| FY2022 | 64.2% | 64.2% | -34.3% |
| FY2023 | -25.8% | -25.8% | -24.3% |
| FY2024 | -24.1% | -24.1% | -22.7% |
| FY2025 | -32.9% | -32.9% | -30.6% |